Literature DB >> 22543117

Seed migration in prostate brachytherapy depends on experience and technique.

Daniel Taussky1, Camille Moumdjian, Renée Larouche, Dominic Béliveau-Nadeau, Chantal Boudreau, Yannick Hervieux, David Donath.   

Abstract

PURPOSE: To determine seed loss and pulmonary migration rate over time in permanent seed prostate brachytherapy. METHODS AND MATERIALS: We analyzed the first 495 patients treated in our department. All patients were treated with loose (125)I seeds with automated seed delivery system and real-time intraoperative planning. Pelvic fluoroscopic imaging was done 30 days after the implant. Patients were divided into five groups of 100 patients according to the order they were treated, and groups were compared using χ(2) test and one-way analysis of variance.
RESULTS: A total of 22.8% of patients lost at least one seed. The highest percentage of patients losing any number of seeds was in the first 100. Thirty-eight percent lost at least one seed. This number decreased gradually and was only 9% in Patients 400-499. The mean total seed loss rate (number of seeds lost/number seeds implanted) changed significantly over time (p<0.001). There was a continuous significant (p<0.001) decline after the first 100 patients (1.25% for the first 100 patients) followed by a rise in Patients 300-399, followed by another decline (0.21% for the last 100 patients). The seed loss rate to the thorax changed significantly over time (p=0.009). It rose after an initial rate of 0.25-0.42% in Patients 200-299 and 300-399 and declined later to a rate of 0.21% in the last 100 patients.
CONCLUSIONS: We found a learning curve for seed migration. Avoiding implanting seeds outside of the capsule and modern transrectal ultrasound imaging can help decrease migration.
Copyright © 2012 American Brachytherapy Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22543117     DOI: 10.1016/j.brachy.2012.03.003

Source DB:  PubMed          Journal:  Brachytherapy        ISSN: 1538-4721            Impact factor:   2.362


  9 in total

1.  Institutional patient accrual volume and the treatment quality of I‑125 prostate seed implantation in a Japanese nationwide prospective cohort study.

Authors:  Katsumasa Nakamura; Saiji Ohga; Atsunori Yorozu; Shiro Saito; Takashi Kikuchi; Takushi Dokiya; Masanori Fukushima; Hidetoshi Yamanaka
Journal:  Strahlenther Onkol       Date:  2018-12-05       Impact factor: 3.621

2.  Seed loss in prostate brachytherapy : Operator dependency and impact on dosimetry.

Authors:  Nancy El-Bared; Natanel Sebbag; Dominic Béliveau-Nadeau; Yannick Hervieux; Renée Larouche; Daniel Taussky; Guila Delouya
Journal:  Strahlenther Onkol       Date:  2016-02-29       Impact factor: 3.621

3.  Prostate Brachytherapy seed migration to the Bladder presenting with Gross Hematuria.

Authors:  Reham R Haroun; John W Nance; Elliot K Fishman
Journal:  J Radiol Case Rep       Date:  2016-01-31

4.  Evaluation of the dosimetric impact of loss and displacement of seeds in prostate low-dose-rate brachytherapy.

Authors:  Yinkun Wang; Nicola J Nasser; Jette Borg; Elantholi P Saibishkumar
Journal:  J Contemp Brachytherapy       Date:  2015-06-09

5.  Pulmonary metastases after low-dose-rate brachytherapy for localized prostate cancer.

Authors:  Masahito Kido; Hidetoshi Kuruma; Hiroshi Sasaki; Kenta Miki; Manabu Aoki; Takahiro Kimura; Hiroyuki Takahash; Chihiro Kanehira; Shin Egawa
Journal:  Korean J Urol       Date:  2014-05-12

6.  Iodine-125 seed brachytherapy for early stage prostate cancer: a single-institution review.

Authors:  Simon Zuber; Susan Weiß; Dieter Baaske; Michael Schöpe; Simon Stevens; Stephan Bodis; Daniel R Zwahlen
Journal:  Radiat Oncol       Date:  2015-02-22       Impact factor: 3.481

7.  Late seed migration after prostate brachytherapy with Iod-125 permanent implants.

Authors:  Philipp Maletzki; Christoph Schwab; Patrick Markart; Daniel Engeler; Johann Schiefer; Ludwig Plasswilm; Hans-Peter Schmid
Journal:  Prostate Int       Date:  2017-09-30

8.  Investigating the displacement of radio-active sources during gold-198 grain brachytherapy for hospitalized oral cancer patients.

Authors:  Masaru Konishi; Yuki Takeuchi; Katsumaro Kubo; Nobuki Imano; Ikuno Nishibuchi; Yuji Murakami; Kiichi Shimabukuro; Pongsapak Wongratwanich; Naoya Kakimoto; Yasushi Nagata
Journal:  J Contemp Brachytherapy       Date:  2022-03-23

9.  Seed migration after transperineal interstitial prostate brachytherapy by using loose seeds: Japanese prostate cancer outcome study of permanent iodine-125 seed implantation (J-POPS) multi-institutional cohort study.

Authors:  Masahiro Nakano; Atsunori Yorozu; Shiro Saito; Akitomo Sugawara; Shinichiroh Maruo; Shinsuke Kojima; Takashi Kikuchi; Masanori Fukushima; Takushi Dokiya; Hidetoshi Yamanaka
Journal:  Radiat Oncol       Date:  2015-11-14       Impact factor: 3.481

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.